W. Cai, L. Hu, and J. G. Foulkes, Transcriptionmodulating drugs: mechanism and selectivity, Curr. Opin. Biotechnol, vol.7, pp.608-615, 1996.
DOI : 10.1016/s0958-1669(96)80071-1

J. E. Darnell and . Jr, Transcription factors as targets for cancer therapy, Nat. Rev. Cancer, vol.2, pp.740-749, 2002.

G. N. Kovacevic, M. Mojsin, A. Krstic, and M. Stevanovic, Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity, Gene, vol.344, pp.287-297

X. Zhu, J. Jiang, H. Shen, H. Wang, H. Zong et al., Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator, J. Biol. Chem, vol.280, pp.12503-12516

A. En-nia, E. Yilmaz, U. Klinge, D. H. Lovett, I. Stefanidis et al., Transcription factor YB-1 mediates DNA polymerase alpha gene expression, J. Biol. Chem, vol.280, pp.7702-7711
DOI : 10.1074/jbc.m413353200

Z. Li, J. Niu, T. Uwagawa, B. Peng, and P. J. Chiao, Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response, J. Biol. Chem, vol.280, pp.16843-16850

H. B. Sun, G. M. Malacinski, and H. Yokota, Promoter competition assay for analyzing gene regulation in joint tissue engineering, Front Biosci, vol.7, pp.169-174

F. Hube, P. Reverdiau, S. Iochmann, C. Cherpi-antar, and Y. Gruel, Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line, Thromb. Res, vol.109, pp.207-215
URL : https://hal.archives-ouvertes.fr/hal-02127781

K. Quandt, K. Frech, H. Karas, E. Wingender, and T. Werner, MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data, Nucleic Acids Res, vol.23, pp.12-23

E. Wingender, X. Chen, E. Fricke, R. Geffers, R. Hehl et al., The TRANSFAC system on gene expression regulation, Nucleic Acids Res, vol.29, pp.281-283, 2001.

S. Fimmel, A. Saborowski, C. E. Orfanos, and C. C. Zouboulis, Development of efficient transient transfection systems for introducing antisense oligonucleotides into human epithelial skin cells, Horm. Res, vol.54, pp.306-311, 2000.

R. V. Giles, D. G. Spiller, J. Grzybowski, R. E. Clark, P. Nicklin et al., Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells, Nucleic Acids Res, vol.26, pp.1567-1575
DOI : 10.1093/nar/26.7.1567
URL : https://academic.oup.com/nar/article-pdf/26/7/1567/6240102/26-7-1567.pdf

M. J. Ferber and L. J. Maher, III: Quantitating oligonucleotide affinities for duplex DNA: footprinting vs electrophoretic mobility shift assays, Anal. Biochem, vol.244, pp.312-320

B. Peng, B. Lu, E. Leygue, and L. C. Murphy, Putative functional characteristics of human estrogen receptor-beta isoforms, J. Mol. Endocrinol, vol.30, pp.13-29, 2003.

R. A. Moxley, H. W. Jarrett, and S. Mitra, Methods for transcription factor separation, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci, vol.797, pp.269-288
DOI : 10.1016/s1570-0232(03)00609-3

R. A. Moxley and H. W. Jarrett, Oligonucleotide trapping method for transcription factor purification systematic optimization using electrophoretic mobility shift assay, J. Chromatogr. A, vol.1070, pp.23-34
DOI : 10.1016/j.chroma.2005.02.012

A. Rocha, S. Ruiz, and J. M. Coll, Improvement of DNA transfection with cationic liposomes, J. Physiol Biochem, vol.58, pp.45-56, 2002.

D. D. Zhao, S. Watarai, J. T. Lee, S. Kouchi, H. Ohmori et al., Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids, Acta Med. Okayama, vol.51, pp.149-154, 1997.

C. Leroy, D. Manen, R. Rizzoli, M. Lombes, and C. Silve, Functional importance of Myc-associated zinc finger protein for the human parathyroid hormone (PTH)/PTHrelated peptide receptor-1 P2 promoter constitutive activity, J. Mol. Endocrinol, vol.32, pp.99-113, 2004.

D. R. Hesselbrock, N. Kurpios, J. A. Hassell, M. A. Watson, and T. P. Fleming, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin, Breast Cancer Res. Treat, vol.89, pp.289-296, 2005.

S. Cheng and S. P. Balk, Steroid hormone receptor signaling in cancer, Cancer Treat. Res, vol.115, pp.293-318, 2003.

A. V. Favorov, M. S. Gelfand, A. V. Gerasimova, D. A. Ravcheev, A. A. Mironov et al., A Gibbs sampler for identification of symmetrically structured, spaced DNA motifs with improved estimation of the signal length, Bioinformatics, vol.21, pp.2240-2245

Y. Pilpel, P. Sudarsanam, and G. M. Church, Identifying regulatory networks by combinatorial analysis of promoter elements, Nat. Genet, vol.29, pp.153-159, 2001.

S. Boulon, J. C. Dantonel, V. Binet, A. Vie, J. M. Blanchard et al., Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho, Mol. Cell Biol, vol.22, pp.7769-7779, 2002.

L. Cicatiello, R. Addeo, A. Sasso, L. Altucci, V. B. Petrizzi et al., Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter, Mol. Cell Biol, vol.24, pp.7260-7274, 2004.

J. W. Voss, L. Wilson, and M. G. Rosenfeld, POUdomain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter, Genes Dev, vol.5, pp.1309-1320, 1991.

F. Q. Zhao, K. Adachi, and T. Oka, Involvement of Oct-1 in transcriptional regulation of beta-casein gene expression in mouse mammary gland, Biochim. Biophys. Acta, vol.1577, pp.27-37, 2002.